Delivery Order SPE2DB20D1050-SPE2DB25FH79G
Award Date 7/23/25
Potential Completion Date 7/24/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,751.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for ENGERIX-B 20 MCG/ML vaccine syringes. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $2,239.14 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. This non-competitive, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used in military and federal healthcare settings for immunization programs across the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B PEDI 10 MCG/0.5 SYRINGE in 0.5ML units, valued at $1,557.82. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used in pediatric immunization programs, indicating this delivery supports...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for $1,416.30 to supply ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,447.26 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRINGE 0.5ML, a pediatric hepatitis B vaccine product. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, was competitively awarded with no set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for ENGERIX-B 20 mcg/mL syringes valued at $1,382.45. This competitive, non-set-aside delivery order is scheduled for completion by July 21, 2025, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine product, reflecting the federal government's ongoing pharmaceutical supply requirements for military and defense healthcare...
- The Defense Logistics Agency awarded a $1,416.30 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $5,149.00 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine product. This firm fixed-price delivery order, awarded on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a competitively awarded, non-set-aside contract. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,854.18 to AmerisourceBergen Drug Corp for ENGERIX-B 20 mcg/mL syringes on August 19, 2025, with ultimate completion by August 20, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used across federal healthcare systems to support immunization programs for military personnel, veterans,...
- The Defense Logistics Agency awarded a delivery order valued at $2,713.02 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML syringes, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the company's role as a critical pharmaceutical supplier to federal healthcare systems. The contract was executed on July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...